• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 11th February 2014

Social Preferences and Burden of Illness in Value-based Assessments

This recent research is intended to inform changes in NICE’s approach to assessing the value of medical technologies. Throughout the year, OHE presents a number of Lunchtime Seminars intended to discuss important current issues in health economics. On 30 January,…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

This recent research is intended to inform changes in NICE’s approach to assessing the value of medical technologies.
Throughout the year, OHE presents a number of Lunchtime Seminars intended to discuss important current issues in health economics. On 30 January, OHE invited Dr Donna Rowen of the University of Sheffield to present her recent research on defining social preferences.

Throughout the year, OHE presents a number of Lunchtime Seminars intended to discuss important current issues in health economics. On 30 January, OHE invited Dr Donna Rowen of the University of Sheffield to present her recent research on defining social preferences.

Dr Rowen’s seminar presentation was based on the results of a recent paper, Eliciting societal preferences for burden of illness, therapeutic improvement and end of life for value based pricing, which she co-authored with colleagues in the Department of Health Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) at the University of Sheffield. The paper uses evidence from a large, online, discrete-choice experiment to measure the public’s preferences about assigning treatment priority based on severity of illness, likely gain in quality of life, and whether a patient is near the end of life. Survey participants were asked to indicate which patient subgroups should be assigned higher priority by the NHS, allowing the authors to calculate the strength of any social preference for providing health care to the sickest patients first.

The research is intended to inform changes in 2014 in NICE’s methods of value assessment. NICE may replace the existing system of QALY multipliers for end-of-life patients with a more detailed system of burden-of-illness weights derived from the results of the studies by Dr Rowen and colleagues.

The slides for this presentation may be viewed and downloaded by clicking here.

OHE’s Koonal Shah also has been involved in research intended to determine public preferences and assess alternative methods for collecting such perspectives. His research, undertaken in collaboration with colleagues from the University of Sheffield, used similar methods and focused specifically on attitudes towards assigning priority for end-of-life treatment. However, Koonal’s study presented information to survey participants in slightly different, but potentially important ways, such as describing each patient’s gain from treatment rather than health status or life expectancy as the result of treatment.

In January, Koonal presented his findings at the University of Oxford as part of the Health Economics Research Seminar Series at the University of Oxford. His presentation appears below.

Valuing Health at the End of Life: Defining Public Preferences from Office of Health Economics

Koonal’s related publications include:

Shah, K.K., Tsuchiya, A. & Wailoo, A.J., 2013. Valuing health at the end of life: an empirical study of public preferences. European Journal of Health Economics, Epub ahead of print. doi: 10.1007/s10198-013-0482-3.

Shah, K. & Devlin, N., 2012. Understanding social preferences regarding the prioritisation of treatments addressing unmet need and severity. Research Paper 12/05, London: Office of Health Economics.

Shah, K., Praet, C., Devlin, N., Sussex, J., Appleby J. & Parkin, D., 2012. Is the aim of the English health care system to maximize QALYs? Journal of Health Services Research and Policy, 17(3), pp. 157-164.

Shah, K., Tsuchiya, A., Risa Hole, A. & Wailoo, A., 2012. Valuing health at the end of life: a stated preference discrete choice experiment. NICE Decision Support Unit report. Sheffield: Decision Support Unit.

For further information, please contact Koonal Shah.

  • Healthcare Systems
  • Value, Affordability, and…
  • Events

Related News

MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
  • News
  • November 2021

Opportunity Cost in Health Care: a Favourite Research Topic for OHE

Read more
  • News
  • September 2020

Assessing the Productivity Value of Vaccines in Health Technology Assessment: Worth a Shot?

Read more
  • News
  • August 2020

Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!